ArticleOncogene2024

Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT).

Matthew J Hadfield et al.PubMed ↗Publisher ↗

No numbers read from the abstract.